nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Nicotine—ulcerative colitis	0.0852	0.193	CbGbCtD
Fingolimod—CYP3A4—Budesonide—ulcerative colitis	0.0593	0.134	CbGbCtD
Fingolimod—CYP2D6—Nicotine—ulcerative colitis	0.0406	0.0918	CbGbCtD
Fingolimod—CYP2D6—Cholecalciferol—ulcerative colitis	0.0364	0.0823	CbGbCtD
Fingolimod—CYP2E1—Dexamethasone—ulcerative colitis	0.0331	0.0748	CbGbCtD
Fingolimod—CYP3A4—Methylprednisolone—ulcerative colitis	0.0265	0.0599	CbGbCtD
Fingolimod—CYP3A4—Nicotine—ulcerative colitis	0.0258	0.0584	CbGbCtD
Fingolimod—CYP3A4—Cholecalciferol—ulcerative colitis	0.0232	0.0524	CbGbCtD
Fingolimod—CYP3A4—Triamcinolone—ulcerative colitis	0.0201	0.0454	CbGbCtD
Fingolimod—CYP3A4—Betamethasone—ulcerative colitis	0.0172	0.0389	CbGbCtD
Fingolimod—CYP3A4—Prednisolone—ulcerative colitis	0.017	0.0384	CbGbCtD
Fingolimod—CYP3A4—Hydrocortisone—ulcerative colitis	0.0161	0.0364	CbGbCtD
Fingolimod—CYP3A4—Prednisone—ulcerative colitis	0.0161	0.0363	CbGbCtD
Fingolimod—CYP2D6—Dexamethasone—ulcerative colitis	0.0158	0.0356	CbGbCtD
Fingolimod—S1PR4—lymphoid tissue—ulcerative colitis	0.0103	0.0922	CbGeAlD
Fingolimod—CYP3A4—Dexamethasone—ulcerative colitis	0.01	0.0227	CbGbCtD
Fingolimod—S1PR3—smooth muscle tissue—ulcerative colitis	0.009	0.0805	CbGeAlD
Fingolimod—S1PR5—lymphoid tissue—ulcerative colitis	0.00866	0.0774	CbGeAlD
Fingolimod—S1PR1—epithelium—ulcerative colitis	0.00824	0.0737	CbGeAlD
Fingolimod—CYP4F2—digestive system—ulcerative colitis	0.00802	0.0717	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—ulcerative colitis	0.00794	0.071	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—ulcerative colitis	0.00785	0.0702	CbGeAlD
Fingolimod—S1PR3—lymphoid tissue—ulcerative colitis	0.0072	0.0644	CbGeAlD
Fingolimod—S1PR5—liver—ulcerative colitis	0.00637	0.057	CbGeAlD
Fingolimod—S1PR1—lymphoid tissue—ulcerative colitis	0.00634	0.0567	CbGeAlD
Fingolimod—CYP4F2—liver—ulcerative colitis	0.00597	0.0534	CbGeAlD
Fingolimod—CYP4F12—digestive system—ulcerative colitis	0.00596	0.0533	CbGeAlD
Fingolimod—S1PR3—liver—ulcerative colitis	0.0053	0.0474	CbGeAlD
Fingolimod—S1PR1—liver—ulcerative colitis	0.00467	0.0418	CbGeAlD
Fingolimod—CYP4F12—liver—ulcerative colitis	0.00444	0.0397	CbGeAlD
Fingolimod—Visual acuity reduced—Dexamethasone—ulcerative colitis	0.00122	0.00691	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Budesonide—ulcerative colitis	0.00121	0.131	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Budesonide—ulcerative colitis	0.00121	0.131	CbGdCrCtD
Fingolimod—Gastroenteritis—Budesonide—ulcerative colitis	0.0012	0.00681	CcSEcCtD
Fingolimod—Eczema—Budesonide—ulcerative colitis	0.00118	0.00672	CcSEcCtD
Fingolimod—Sinusitis—Nicotine—ulcerative colitis	0.00112	0.00634	CcSEcCtD
Fingolimod—Migraine—Budesonide—ulcerative colitis	0.00105	0.00594	CcSEcCtD
Fingolimod—CYP2E1—lymphoid tissue—ulcerative colitis	0.00102	0.0091	CbGeAlD
Fingolimod—CYP2E1—digestive system—ulcerative colitis	0.001	0.00898	CbGeAlD
Fingolimod—Cardiac disorder—Nicotine—ulcerative colitis	0.000992	0.00563	CcSEcCtD
Fingolimod—Gastroenteritis—Mesalazine—ulcerative colitis	0.000976	0.00554	CcSEcCtD
Fingolimod—Alopecia—Mercaptopurine—ulcerative colitis	0.000974	0.00553	CcSEcCtD
Fingolimod—Mediastinal disorder—Nicotine—ulcerative colitis	0.000963	0.00547	CcSEcCtD
Fingolimod—Eczema—Mesalazine—ulcerative colitis	0.000963	0.00546	CcSEcCtD
Fingolimod—Blood triglycerides increased—Prednisone—ulcerative colitis	0.000962	0.00546	CcSEcCtD
Fingolimod—Eye pain—Mesalazine—ulcerative colitis	0.000958	0.00544	CcSEcCtD
Fingolimod—Mental disorder—Nicotine—ulcerative colitis	0.000936	0.00531	CcSEcCtD
Fingolimod—Influenza—Budesonide—ulcerative colitis	0.000919	0.00522	CcSEcCtD
Fingolimod—Back pain—Nicotine—ulcerative colitis	0.0009	0.00511	CcSEcCtD
Fingolimod—Bronchitis—Budesonide—ulcerative colitis	0.000884	0.00502	CcSEcCtD
Fingolimod—Leukopenia—Mercaptopurine—ulcerative colitis	0.000859	0.00488	CcSEcCtD
Fingolimod—Migraine—Mesalazine—ulcerative colitis	0.000851	0.00483	CcSEcCtD
Fingolimod—Palpitations—Nicotine—ulcerative colitis	0.000822	0.00467	CcSEcCtD
Fingolimod—Infestation—Budesonide—ulcerative colitis	0.00082	0.00465	CcSEcCtD
Fingolimod—Infestation NOS—Budesonide—ulcerative colitis	0.00082	0.00465	CcSEcCtD
Fingolimod—Cough—Nicotine—ulcerative colitis	0.000812	0.00461	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000811	0.00461	CcSEcCtD
Fingolimod—CYP3A4—digestive system—ulcerative colitis	0.000808	0.00723	CbGeAlD
Fingolimod—Hypertension—Nicotine—ulcerative colitis	0.000803	0.00456	CcSEcCtD
Fingolimod—Liver function test abnormal—Mesalazine—ulcerative colitis	0.000799	0.00453	CcSEcCtD
Fingolimod—CYP2D6—digestive system—ulcerative colitis	0.000796	0.00711	CbGeAlD
Fingolimod—Aspartate aminotransferase increased—Mesalazine—ulcerative colitis	0.000779	0.00442	CcSEcCtD
Fingolimod—Sinusitis—Budesonide—ulcerative colitis	0.000769	0.00437	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Mesalazine—ulcerative colitis	0.000763	0.00433	CcSEcCtD
Fingolimod—Skin disorder—Mercaptopurine—ulcerative colitis	0.000761	0.00432	CcSEcCtD
Fingolimod—CYP2E1—liver—ulcerative colitis	0.000749	0.00669	CbGeAlD
Fingolimod—Influenza—Mesalazine—ulcerative colitis	0.000748	0.00424	CcSEcCtD
Fingolimod—Nervous system disorder—Nicotine—ulcerative colitis	0.000744	0.00423	CcSEcCtD
Fingolimod—Pneumonia—Azathioprine—ulcerative colitis	0.000736	0.00418	CcSEcCtD
Fingolimod—Infestation NOS—Azathioprine—ulcerative colitis	0.000732	0.00415	CcSEcCtD
Fingolimod—Infestation—Azathioprine—ulcerative colitis	0.000732	0.00415	CcSEcCtD
Fingolimod—Connective tissue disorder—Budesonide—ulcerative colitis	0.000723	0.0041	CcSEcCtD
Fingolimod—Bronchitis—Mesalazine—ulcerative colitis	0.000719	0.00408	CcSEcCtD
Fingolimod—Hypotension—Nicotine—ulcerative colitis	0.000709	0.00403	CcSEcCtD
Fingolimod—Gastroenteritis—Hydrocortisone—ulcerative colitis	0.000694	0.00394	CcSEcCtD
Fingolimod—Eye disorder—Budesonide—ulcerative colitis	0.000688	0.0039	CcSEcCtD
Fingolimod—Eczema—Hydrocortisone—ulcerative colitis	0.000684	0.00389	CcSEcCtD
Fingolimod—Cardiac disorder—Budesonide—ulcerative colitis	0.000683	0.00388	CcSEcCtD
Fingolimod—Paraesthesia—Nicotine—ulcerative colitis	0.000682	0.00387	CcSEcCtD
Fingolimod—Dyspnoea—Nicotine—ulcerative colitis	0.000677	0.00384	CcSEcCtD
Fingolimod—Weight decreased—Mesalazine—ulcerative colitis	0.000676	0.00384	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000676	0.00384	CcSEcCtD
Fingolimod—Pneumonia—Mesalazine—ulcerative colitis	0.00067	0.00381	CcSEcCtD
Fingolimod—Angiopathy—Budesonide—ulcerative colitis	0.000668	0.00379	CcSEcCtD
Fingolimod—Infestation—Mesalazine—ulcerative colitis	0.000667	0.00378	CcSEcCtD
Fingolimod—Infestation NOS—Mesalazine—ulcerative colitis	0.000667	0.00378	CcSEcCtD
Fingolimod—Depression—Mesalazine—ulcerative colitis	0.000665	0.00377	CcSEcCtD
Fingolimod—Mediastinal disorder—Budesonide—ulcerative colitis	0.000663	0.00376	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000655	0.00372	CcSEcCtD
Fingolimod—Fatigue—Nicotine—ulcerative colitis	0.000654	0.00371	CcSEcCtD
Fingolimod—Alopecia—Budesonide—ulcerative colitis	0.00065	0.00369	CcSEcCtD
Fingolimod—Mental disorder—Budesonide—ulcerative colitis	0.000645	0.00366	CcSEcCtD
Fingolimod—Sinusitis—Mesalazine—ulcerative colitis	0.000625	0.00355	CcSEcCtD
Fingolimod—Back pain—Budesonide—ulcerative colitis	0.00062	0.00352	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000619	0.0672	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Hydrocortisone—ulcerative colitis	0.000619	0.0672	CbGdCrCtD
Fingolimod—Vision blurred—Budesonide—ulcerative colitis	0.000604	0.00343	CcSEcCtD
Fingolimod—CYP3A4—liver—ulcerative colitis	0.000602	0.00539	CbGeAlD
Fingolimod—Cardiac arrest—Prednisolone—ulcerative colitis	0.000599	0.0034	CcSEcCtD
Fingolimod—CYP2D6—liver—ulcerative colitis	0.000593	0.0053	CbGeAlD
Fingolimod—Mediastinal disorder—Azathioprine—ulcerative colitis	0.000592	0.00336	CcSEcCtD
Fingolimod—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000588	0.00334	CcSEcCtD
Fingolimod—Cardiac arrest—Hydrocortisone—ulcerative colitis	0.000585	0.00332	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Methylprednisolone—ulcerative colitis	0.000584	0.0635	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000584	0.0635	CbGdCrCtD
Fingolimod—Eye pain—Dexamethasone—ulcerative colitis	0.000582	0.0033	CcSEcCtD
Fingolimod—Eye pain—Betamethasone—ulcerative colitis	0.000582	0.0033	CcSEcCtD
Fingolimod—Alopecia—Azathioprine—ulcerative colitis	0.000581	0.0033	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Dexamethasone—ulcerative colitis	0.000575	0.0625	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Betamethasone—ulcerative colitis	0.000575	0.0625	CbGdCrCtD
Fingolimod—Palpitations—Budesonide—ulcerative colitis	0.000566	0.00321	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Triamcinolone—ulcerative colitis	0.000562	0.061	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Triamcinolone—ulcerative colitis	0.000562	0.061	CbGdCrCtD
Fingolimod—Eye disorder—Mesalazine—ulcerative colitis	0.000559	0.00317	CcSEcCtD
Fingolimod—Cough—Budesonide—ulcerative colitis	0.000559	0.00317	CcSEcCtD
Fingolimod—Cardiac disorder—Mesalazine—ulcerative colitis	0.000555	0.00315	CcSEcCtD
Fingolimod—Hypertension—Budesonide—ulcerative colitis	0.000553	0.00314	CcSEcCtD
Fingolimod—Cardiac arrest—Triamcinolone—ulcerative colitis	0.000551	0.00313	CcSEcCtD
Fingolimod—Cardiac arrest—Methylprednisolone—ulcerative colitis	0.000549	0.00312	CcSEcCtD
Fingolimod—Asthenia—Nicotine—ulcerative colitis	0.000545	0.00309	CcSEcCtD
Fingolimod—Angiopathy—Mesalazine—ulcerative colitis	0.000543	0.00308	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000542	0.00308	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000542	0.00307	CcSEcCtD
Fingolimod—Mediastinal disorder—Mesalazine—ulcerative colitis	0.000539	0.00306	CcSEcCtD
Fingolimod—Pruritus—Nicotine—ulcerative colitis	0.000537	0.00305	CcSEcCtD
Fingolimod—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000536	0.00304	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—ulcerative colitis	0.000533	0.0579	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisone—ulcerative colitis	0.000533	0.0579	CbGdCrCtD
Fingolimod—Alopecia—Mesalazine—ulcerative colitis	0.000529	0.003	CcSEcCtD
Fingolimod—Mental disorder—Mesalazine—ulcerative colitis	0.000524	0.00298	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Prednisolone—ulcerative colitis	0.00052	0.0565	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisolone—ulcerative colitis	0.00052	0.0565	CbGdCrCtD
Fingolimod—Diarrhoea—Nicotine—ulcerative colitis	0.000519	0.00295	CcSEcCtD
Fingolimod—Infection—Budesonide—ulcerative colitis	0.000519	0.00295	CcSEcCtD
Fingolimod—Migraine—Betamethasone—ulcerative colitis	0.000517	0.00294	CcSEcCtD
Fingolimod—Migraine—Dexamethasone—ulcerative colitis	0.000517	0.00294	CcSEcCtD
Fingolimod—Nervous system disorder—Budesonide—ulcerative colitis	0.000513	0.00291	CcSEcCtD
Fingolimod—Leukopenia—Azathioprine—ulcerative colitis	0.000512	0.00291	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.00051	0.00289	CcSEcCtD
Fingolimod—Skin disorder—Budesonide—ulcerative colitis	0.000508	0.00288	CcSEcCtD
Fingolimod—Back pain—Mesalazine—ulcerative colitis	0.000504	0.00286	CcSEcCtD
Fingolimod—Dizziness—Nicotine—ulcerative colitis	0.000502	0.00285	CcSEcCtD
Fingolimod—Influenza—Triamcinolone—ulcerative colitis	0.000501	0.00284	CcSEcCtD
Fingolimod—Cardiac arrest—Dexamethasone—ulcerative colitis	0.0005	0.00284	CcSEcCtD
Fingolimod—Cardiac arrest—Betamethasone—ulcerative colitis	0.0005	0.00284	CcSEcCtD
Fingolimod—Vision blurred—Mesalazine—ulcerative colitis	0.000491	0.00279	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000484	0.00274	CcSEcCtD
Fingolimod—Bronchitis—Triamcinolone—ulcerative colitis	0.000481	0.00273	CcSEcCtD
Fingolimod—Weight decreased—Hydrocortisone—ulcerative colitis	0.000481	0.00273	CcSEcCtD
Fingolimod—Headache—Nicotine—ulcerative colitis	0.000476	0.0027	CcSEcCtD
Fingolimod—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000474	0.00269	CcSEcCtD
Fingolimod—Infestation—Hydrocortisone—ulcerative colitis	0.000474	0.00269	CcSEcCtD
Fingolimod—Paraesthesia—Budesonide—ulcerative colitis	0.000469	0.00266	CcSEcCtD
Fingolimod—Leukopenia—Mesalazine—ulcerative colitis	0.000466	0.00265	CcSEcCtD
Fingolimod—Dyspnoea—Budesonide—ulcerative colitis	0.000466	0.00265	CcSEcCtD
Fingolimod—Infection—Azathioprine—ulcerative colitis	0.000464	0.00263	CcSEcCtD
Fingolimod—Palpitations—Mesalazine—ulcerative colitis	0.00046	0.00261	CcSEcCtD
Fingolimod—Cough—Mesalazine—ulcerative colitis	0.000455	0.00258	CcSEcCtD
Fingolimod—Skin disorder—Azathioprine—ulcerative colitis	0.000453	0.00257	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000451	0.00256	CcSEcCtD
Fingolimod—Fatigue—Budesonide—ulcerative colitis	0.000451	0.00256	CcSEcCtD
Fingolimod—Hypertension—Mesalazine—ulcerative colitis	0.00045	0.00255	CcSEcCtD
Fingolimod—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000445	0.00253	CcSEcCtD
Fingolimod—Infestation—Methylprednisolone—ulcerative colitis	0.000445	0.00253	CcSEcCtD
Fingolimod—Bradycardia—Prednisolone—ulcerative colitis	0.000444	0.00252	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00044	0.0025	CcSEcCtD
Fingolimod—Hypotension—Azathioprine—ulcerative colitis	0.000436	0.00248	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—ulcerative colitis	0.000435	0.00247	CcSEcCtD
Fingolimod—Bradycardia—Hydrocortisone—ulcerative colitis	0.000433	0.00246	CcSEcCtD
Fingolimod—Infection—Mesalazine—ulcerative colitis	0.000422	0.0024	CcSEcCtD
Fingolimod—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000418	0.00237	CcSEcCtD
Fingolimod—Nervous system disorder—Mesalazine—ulcerative colitis	0.000417	0.00237	CcSEcCtD
Fingolimod—Skin disorder—Mesalazine—ulcerative colitis	0.000413	0.00234	CcSEcCtD
Fingolimod—Weight decreased—Betamethasone—ulcerative colitis	0.000411	0.00233	CcSEcCtD
Fingolimod—Weight decreased—Dexamethasone—ulcerative colitis	0.000411	0.00233	CcSEcCtD
Fingolimod—Bradycardia—Triamcinolone—ulcerative colitis	0.000408	0.00232	CcSEcCtD
Fingolimod—Bradycardia—Methylprednisolone—ulcerative colitis	0.000407	0.00231	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000404	0.00229	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000403	0.00229	CcSEcCtD
Fingolimod—Eye disorder—Hydrocortisone—ulcerative colitis	0.000398	0.00226	CcSEcCtD
Fingolimod—Hypotension—Mesalazine—ulcerative colitis	0.000397	0.00226	CcSEcCtD
Fingolimod—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000393	0.00223	CcSEcCtD
Fingolimod—Paraesthesia—Mesalazine—ulcerative colitis	0.000382	0.00217	CcSEcCtD
Fingolimod—Dyspnoea—Mesalazine—ulcerative colitis	0.000379	0.00215	CcSEcCtD
Fingolimod—Asthenia—Budesonide—ulcerative colitis	0.000375	0.00213	CcSEcCtD
Fingolimod—Eye disorder—Methylprednisolone—ulcerative colitis	0.000374	0.00212	CcSEcCtD
Fingolimod—Mental disorder—Hydrocortisone—ulcerative colitis	0.000373	0.00212	CcSEcCtD
Fingolimod—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000371	0.00211	CcSEcCtD
Fingolimod—Bradycardia—Betamethasone—ulcerative colitis	0.00037	0.0021	CcSEcCtD
Fingolimod—Bradycardia—Dexamethasone—ulcerative colitis	0.00037	0.0021	CcSEcCtD
Fingolimod—Pruritus—Budesonide—ulcerative colitis	0.00037	0.0021	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000367	0.00208	CcSEcCtD
Fingolimod—Fatigue—Mesalazine—ulcerative colitis	0.000367	0.00208	CcSEcCtD
Fingolimod—Angiopathy—Methylprednisolone—ulcerative colitis	0.000363	0.00206	CcSEcCtD
Fingolimod—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00036	0.00205	CcSEcCtD
Fingolimod—Weight decreased—Prednisone—ulcerative colitis	0.000358	0.00203	CcSEcCtD
Fingolimod—Diarrhoea—Budesonide—ulcerative colitis	0.000358	0.00203	CcSEcCtD
Fingolimod—Vision blurred—Prednisolone—ulcerative colitis	0.000357	0.00203	CcSEcCtD
Fingolimod—Depression—Prednisone—ulcerative colitis	0.000352	0.002	CcSEcCtD
Fingolimod—Mental disorder—Methylprednisolone—ulcerative colitis	0.00035	0.00199	CcSEcCtD
Fingolimod—Dizziness—Budesonide—ulcerative colitis	0.000346	0.00196	CcSEcCtD
Fingolimod—Eye disorder—Dexamethasone—ulcerative colitis	0.00034	0.00193	CcSEcCtD
Fingolimod—Eye disorder—Betamethasone—ulcerative colitis	0.00034	0.00193	CcSEcCtD
Fingolimod—Back pain—Triamcinolone—ulcerative colitis	0.000337	0.00192	CcSEcCtD
Fingolimod—Angiopathy—Betamethasone—ulcerative colitis	0.00033	0.00187	CcSEcCtD
Fingolimod—Angiopathy—Dexamethasone—ulcerative colitis	0.00033	0.00187	CcSEcCtD
Fingolimod—Headache—Budesonide—ulcerative colitis	0.000327	0.00186	CcSEcCtD
Fingolimod—Hypertension—Prednisolone—ulcerative colitis	0.000327	0.00186	CcSEcCtD
Fingolimod—Bradycardia—Prednisone—ulcerative colitis	0.000322	0.00183	CcSEcCtD
Fingolimod—Alopecia—Dexamethasone—ulcerative colitis	0.000321	0.00182	CcSEcCtD
Fingolimod—Alopecia—Betamethasone—ulcerative colitis	0.000321	0.00182	CcSEcCtD
Fingolimod—Hypertension—Hydrocortisone—ulcerative colitis	0.00032	0.00182	CcSEcCtD
Fingolimod—Diarrhoea—Azathioprine—ulcerative colitis	0.000319	0.00181	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000313	0.00178	CcSEcCtD
Fingolimod—Connective tissue disorder—Prednisone—ulcerative colitis	0.000311	0.00177	CcSEcCtD
Fingolimod—Dizziness—Azathioprine—ulcerative colitis	0.000309	0.00175	CcSEcCtD
Fingolimod—Asthenia—Mesalazine—ulcerative colitis	0.000305	0.00173	CcSEcCtD
Fingolimod—Cough—Triamcinolone—ulcerative colitis	0.000304	0.00173	CcSEcCtD
Fingolimod—Hypertension—Triamcinolone—ulcerative colitis	0.000301	0.00171	CcSEcCtD
Fingolimod—Pruritus—Mesalazine—ulcerative colitis	0.000301	0.00171	CcSEcCtD
Fingolimod—Hypertension—Methylprednisolone—ulcerative colitis	0.0003	0.00171	CcSEcCtD
Fingolimod—Infection—Hydrocortisone—ulcerative colitis	0.0003	0.0017	CcSEcCtD
Fingolimod—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000296	0.00168	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—ulcerative colitis	0.000296	0.00168	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000294	0.00167	CcSEcCtD
Fingolimod—Skin disorder—Hydrocortisone—ulcerative colitis	0.000294	0.00167	CcSEcCtD
Fingolimod—Headache—Azathioprine—ulcerative colitis	0.000292	0.00166	CcSEcCtD
Fingolimod—Diarrhoea—Mesalazine—ulcerative colitis	0.000291	0.00165	CcSEcCtD
Fingolimod—Angiopathy—Prednisone—ulcerative colitis	0.000287	0.00163	CcSEcCtD
Fingolimod—Infection—Triamcinolone—ulcerative colitis	0.000283	0.00161	CcSEcCtD
Fingolimod—Hypotension—Hydrocortisone—ulcerative colitis	0.000282	0.0016	CcSEcCtD
Fingolimod—Infection—Methylprednisolone—ulcerative colitis	0.000282	0.0016	CcSEcCtD
Fingolimod—Dizziness—Mesalazine—ulcerative colitis	0.000281	0.0016	CcSEcCtD
Fingolimod—Alopecia—Prednisone—ulcerative colitis	0.00028	0.00159	CcSEcCtD
Fingolimod—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000279	0.00158	CcSEcCtD
Fingolimod—Paraesthesia—Prednisolone—ulcerative colitis	0.000278	0.00158	CcSEcCtD
Fingolimod—Mental disorder—Prednisone—ulcerative colitis	0.000277	0.00157	CcSEcCtD
Fingolimod—Skin disorder—Methylprednisolone—ulcerative colitis	0.000276	0.00157	CcSEcCtD
Fingolimod—Hypertension—Betamethasone—ulcerative colitis	0.000273	0.00155	CcSEcCtD
Fingolimod—Hypertension—Dexamethasone—ulcerative colitis	0.000273	0.00155	CcSEcCtD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000272	0.00104	CbGpPWpGaD
Fingolimod—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000271	0.00154	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—GHRL—ulcerative colitis	0.000271	0.00104	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—GHRL—ulcerative colitis	0.000271	0.00104	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—GHRL—ulcerative colitis	0.000271	0.00104	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SEL1L—ulcerative colitis	0.00027	0.00104	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTGER4—ulcerative colitis	0.000269	0.00103	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTGER4—ulcerative colitis	0.000269	0.00103	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000269	0.00103	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	0.000268	0.00103	CbGpPWpGaD
Fingolimod—Headache—Mesalazine—ulcerative colitis	0.000266	0.00151	CcSEcCtD
Fingolimod—Hypotension—Methylprednisolone—ulcerative colitis	0.000265	0.00151	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000261	0.001	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000261	0.00148	CcSEcCtD
Fingolimod—Fatigue—Hydrocortisone—ulcerative colitis	0.000261	0.00148	CcSEcCtD
Fingolimod—Vision blurred—Prednisone—ulcerative colitis	0.00026	0.00147	CcSEcCtD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000257	0.000987	CbGpPWpGaD
Fingolimod—Infection—Betamethasone—ulcerative colitis	0.000257	0.00146	CcSEcCtD
Fingolimod—Infection—Dexamethasone—ulcerative colitis	0.000257	0.00146	CcSEcCtD
Fingolimod—Paraesthesia—Triamcinolone—ulcerative colitis	0.000256	0.00145	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—GHRL—ulcerative colitis	0.000256	0.000982	CbGpPWpGaD
Fingolimod—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000255	0.00145	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CXCR1—ulcerative colitis	0.000255	0.000978	CbGpPWpGaD
Fingolimod—Dyspnoea—Triamcinolone—ulcerative colitis	0.000254	0.00144	CcSEcCtD
Fingolimod—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000253	0.00144	CcSEcCtD
Fingolimod—Nervous system disorder—Betamethasone—ulcerative colitis	0.000253	0.00144	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—IL6—ulcerative colitis	0.000253	0.000972	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000252	0.000967	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000252	0.000967	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CALM3—ulcerative colitis	0.000248	0.000951	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GHRL—ulcerative colitis	0.000246	0.000945	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GHRL—ulcerative colitis	0.000246	0.000945	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000246	0.000945	CbGpPWpGaD
Fingolimod—Fatigue—Triamcinolone—ulcerative colitis	0.000245	0.00139	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CXCR1—ulcerative colitis	0.000245	0.000941	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR1—ulcerative colitis	0.000245	0.000941	CbGpPWpGaD
Fingolimod—Fatigue—Methylprednisolone—ulcerative colitis	0.000245	0.00139	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000244	0.000937	CbGpPWpGaD
Fingolimod—Hypotension—Betamethasone—ulcerative colitis	0.000241	0.00137	CcSEcCtD
Fingolimod—Hypotension—Dexamethasone—ulcerative colitis	0.000241	0.00137	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—SEL1L—ulcerative colitis	0.000239	0.000919	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CALM3—ulcerative colitis	0.000238	0.000915	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CALM3—ulcerative colitis	0.000238	0.000915	CbGpPWpGaD
Fingolimod—Hypertension—Prednisone—ulcerative colitis	0.000238	0.00135	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000233	0.00132	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000233	0.000895	CbGpPWpGaD
Fingolimod—Paraesthesia—Betamethasone—ulcerative colitis	0.000232	0.00132	CcSEcCtD
Fingolimod—Paraesthesia—Dexamethasone—ulcerative colitis	0.000232	0.00132	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000229	0.000878	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000224	0.000861	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000224	0.000861	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL20—ulcerative colitis	0.000224	0.000858	CbGpPWpGaD
Fingolimod—Infection—Prednisone—ulcerative colitis	0.000223	0.00127	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—GHRL—ulcerative colitis	0.000223	0.000858	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000223	0.00127	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000223	0.00127	CcSEcCtD
Fingolimod—Fatigue—Betamethasone—ulcerative colitis	0.000223	0.00126	CcSEcCtD
Fingolimod—Fatigue—Dexamethasone—ulcerative colitis	0.000223	0.00126	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CXCR1—ulcerative colitis	0.000223	0.000855	CbGpPWpGaD
Fingolimod—Nervous system disorder—Prednisone—ulcerative colitis	0.000221	0.00125	CcSEcCtD
Fingolimod—Skin disorder—Prednisone—ulcerative colitis	0.000218	0.00124	CcSEcCtD
Fingolimod—Asthenia—Hydrocortisone—ulcerative colitis	0.000217	0.00123	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CALM3—ulcerative colitis	0.000216	0.000831	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL20—ulcerative colitis	0.000215	0.000826	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL20—ulcerative colitis	0.000215	0.000826	CbGpPWpGaD
Fingolimod—Pruritus—Hydrocortisone—ulcerative colitis	0.000214	0.00121	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—ADRB2—ulcerative colitis	0.000212	0.000813	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GNA12—ulcerative colitis	0.00021	0.000807	CbGpPWpGaD
Fingolimod—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000207	0.00117	CcSEcCtD
Fingolimod—Dizziness—Prednisolone—ulcerative colitis	0.000205	0.00116	CcSEcCtD
Fingolimod—Asthenia—Triamcinolone—ulcerative colitis	0.000204	0.00116	CcSEcCtD
Fingolimod—Asthenia—Methylprednisolone—ulcerative colitis	0.000204	0.00116	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—ADRB2—ulcerative colitis	0.000204	0.000782	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADRB2—ulcerative colitis	0.000204	0.000782	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000204	0.000782	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS1—ulcerative colitis	0.000203	0.000778	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GNA12—ulcerative colitis	0.000202	0.000777	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GNA12—ulcerative colitis	0.000202	0.000777	CbGpPWpGaD
Fingolimod—Paraesthesia—Prednisone—ulcerative colitis	0.000202	0.00115	CcSEcCtD
Fingolimod—Pruritus—Triamcinolone—ulcerative colitis	0.000201	0.00114	CcSEcCtD
Fingolimod—Pruritus—Methylprednisolone—ulcerative colitis	0.000201	0.00114	CcSEcCtD
Fingolimod—Dizziness—Hydrocortisone—ulcerative colitis	0.0002	0.00113	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CXCR2—ulcerative colitis	0.000199	0.000765	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CXCL8—ulcerative colitis	0.000199	0.000765	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000198	0.00076	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCR1—ulcerative colitis	0.000197	0.000756	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL20—ulcerative colitis	0.000195	0.00075	CbGpPWpGaD
Fingolimod—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000194	0.0011	CcSEcCtD
Fingolimod—Fatigue—Prednisone—ulcerative colitis	0.000194	0.0011	CcSEcCtD
Fingolimod—Headache—Prednisolone—ulcerative colitis	0.000194	0.0011	CcSEcCtD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000193	0.00074	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR2—ulcerative colitis	0.000192	0.000737	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCR2—ulcerative colitis	0.000192	0.000737	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCL8—ulcerative colitis	0.000192	0.000736	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL8—ulcerative colitis	0.000192	0.000736	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000191	0.000735	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00019	0.000731	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00019	0.000731	CbGpPWpGaD
Fingolimod—Headache—Hydrocortisone—ulcerative colitis	0.000189	0.00108	CcSEcCtD
Fingolimod—Dizziness—Triamcinolone—ulcerative colitis	0.000188	0.00107	CcSEcCtD
Fingolimod—Dizziness—Methylprednisolone—ulcerative colitis	0.000188	0.00107	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCR6—ulcerative colitis	0.000187	0.000719	CbGpPWpGaD
Fingolimod—Asthenia—Dexamethasone—ulcerative colitis	0.000185	0.00105	CcSEcCtD
Fingolimod—Asthenia—Betamethasone—ulcerative colitis	0.000185	0.00105	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000185	0.00071	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GNA12—ulcerative colitis	0.000184	0.000706	CbGpPWpGaD
Fingolimod—Pruritus—Dexamethasone—ulcerative colitis	0.000183	0.00104	CcSEcCtD
Fingolimod—Pruritus—Betamethasone—ulcerative colitis	0.000183	0.00104	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—CALM3—ulcerative colitis	0.000182	0.000701	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR6—ulcerative colitis	0.00018	0.000693	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCR6—ulcerative colitis	0.00018	0.000693	CbGpPWpGaD
Fingolimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.00018	0.000691	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—ADCY5—ulcerative colitis	0.00018	0.00069	CbGpPWpGaD
Fingolimod—Headache—Triamcinolone—ulcerative colitis	0.000178	0.00101	CcSEcCtD
Fingolimod—Headache—Methylprednisolone—ulcerative colitis	0.000178	0.00101	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—MAML2—ulcerative colitis	0.000178	0.000682	CbGpPWpGaD
Fingolimod—Diarrhoea—Dexamethasone—ulcerative colitis	0.000177	0.001	CcSEcCtD
Fingolimod—Diarrhoea—Betamethasone—ulcerative colitis	0.000177	0.001	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—PTGS1—ulcerative colitis	0.000175	0.000672	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCR2—ulcerative colitis	0.000174	0.000669	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000174	0.000668	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL20—ulcerative colitis	0.000173	0.000664	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADCY5—ulcerative colitis	0.000173	0.000664	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—ADCY5—ulcerative colitis	0.000173	0.000664	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000173	0.000664	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000172	0.000661	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000171	0.000658	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000171	0.000657	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAML2—ulcerative colitis	0.000171	0.000656	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAML2—ulcerative colitis	0.000171	0.000656	CbGpPWpGaD
Fingolimod—Dizziness—Dexamethasone—ulcerative colitis	0.000171	0.00097	CcSEcCtD
Fingolimod—Dizziness—Betamethasone—ulcerative colitis	0.000171	0.00097	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—MMP1—ulcerative colitis	0.000168	0.000647	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTGER4—ulcerative colitis	0.000165	0.000633	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000164	0.000631	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCR6—ulcerative colitis	0.000164	0.000629	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GNA12—ulcerative colitis	0.000163	0.000624	CbGpPWpGaD
Fingolimod—Headache—Betamethasone—ulcerative colitis	0.000162	0.000919	CcSEcCtD
Fingolimod—Headache—Dexamethasone—ulcerative colitis	0.000162	0.000919	CcSEcCtD
Fingolimod—Asthenia—Prednisone—ulcerative colitis	0.000161	0.000916	CcSEcCtD
Fingolimod—Pruritus—Prednisone—ulcerative colitis	0.000159	0.000903	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—PTGER4—ulcerative colitis	0.000159	0.00061	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTGER4—ulcerative colitis	0.000159	0.00061	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CALM3—ulcerative colitis	0.000157	0.000605	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000157	0.000603	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAML2—ulcerative colitis	0.000155	0.000596	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCR2—ulcerative colitis	0.000154	0.000592	CbGpPWpGaD
Fingolimod—Diarrhoea—Prednisone—ulcerative colitis	0.000154	0.000874	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—GHRL—ulcerative colitis	0.000151	0.00058	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.00015	0.000578	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS1—ulcerative colitis	0.00015	0.000577	CbGpPWpGaD
Fingolimod—Dizziness—Prednisone—ulcerative colitis	0.000149	0.000844	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000148	0.000568	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CALM3—ulcerative colitis	0.000146	0.000562	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GHRL—ulcerative colitis	0.000145	0.000558	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GHRL—ulcerative colitis	0.000145	0.000558	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR6—ulcerative colitis	0.000145	0.000557	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—PTGS1—ulcerative colitis	0.000144	0.000554	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTGER4—ulcerative colitis	0.000144	0.000554	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RIPK2—ulcerative colitis	0.000144	0.000553	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ABCB1—ulcerative colitis	0.000142	0.000545	CbGpPWpGaD
Fingolimod—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000141	0.000543	CbGpPWpGaD
Fingolimod—Headache—Prednisone—ulcerative colitis	0.000141	0.0008	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—CALM3—ulcerative colitis	0.000141	0.000541	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CALM3—ulcerative colitis	0.000141	0.000541	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RIPK2—ulcerative colitis	0.000139	0.000533	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RIPK2—ulcerative colitis	0.000139	0.000533	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAML2—ulcerative colitis	0.000137	0.000528	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CALM3—ulcerative colitis	0.000135	0.00052	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ADCY5—ulcerative colitis	0.000132	0.000508	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GHRL—ulcerative colitis	0.000132	0.000507	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000129	0.000497	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CALM3—ulcerative colitis	0.000128	0.000491	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTGER4—ulcerative colitis	0.000128	0.00049	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000126	0.000484	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RIPK2—ulcerative colitis	0.000126	0.000484	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADRB2—ulcerative colitis	0.000125	0.00048	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—JAK2—ulcerative colitis	0.000123	0.000473	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ABCB1—ulcerative colitis	0.000122	0.00047	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRB2—ulcerative colitis	0.00012	0.000462	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRB2—ulcerative colitis	0.00012	0.000462	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000119	0.000458	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—JAK2—ulcerative colitis	0.000119	0.000456	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—JAK2—ulcerative colitis	0.000119	0.000456	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GHRL—ulcerative colitis	0.000117	0.000449	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ADCY5—ulcerative colitis	0.000114	0.000439	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CALM3—ulcerative colitis	0.000113	0.000434	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000113	0.000432	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—JAK2—ulcerative colitis	0.000112	0.00043	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RIPK2—ulcerative colitis	0.000111	0.000428	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADRB2—ulcerative colitis	0.000109	0.00042	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CXCL8—ulcerative colitis	0.000108	0.000416	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000108	0.000416	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000108	0.000416	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—JAK2—ulcerative colitis	0.000108	0.000414	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—JAK2—ulcerative colitis	0.000108	0.000414	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000108	0.000414	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2—ulcerative colitis	0.000108	0.000413	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADCY5—ulcerative colitis	0.000106	0.000407	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCB1—ulcerative colitis	0.000105	0.000404	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2—ulcerative colitis	0.000104	0.000398	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL2—ulcerative colitis	0.000104	0.000398	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	0.000102	0.000393	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—ulcerative colitis	0.000102	0.000392	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADCY5—ulcerative colitis	0.000102	0.000392	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADCY5—ulcerative colitis	0.000102	0.000392	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PPARG—ulcerative colitis	9.87e-05	0.000379	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—ulcerative colitis	9.84e-05	0.000378	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—ulcerative colitis	9.84e-05	0.000378	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—ulcerative colitis	9.83e-05	0.000378	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ADCY5—ulcerative colitis	9.81e-05	0.000377	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—JAK2—ulcerative colitis	9.79e-05	0.000376	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL2—ulcerative colitis	9.76e-05	0.000375	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADRB2—ulcerative colitis	9.67e-05	0.000371	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2—ulcerative colitis	9.4e-05	0.000361	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL2—ulcerative colitis	9.4e-05	0.000361	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2—ulcerative colitis	9.4e-05	0.000361	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADCY5—ulcerative colitis	9.27e-05	0.000356	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—ulcerative colitis	8.93e-05	0.000343	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ALB—ulcerative colitis	8.87e-05	0.000341	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2—ulcerative colitis	8.53e-05	0.000328	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARG—ulcerative colitis	8.52e-05	0.000327	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADCY5—ulcerative colitis	8.21e-05	0.000315	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—ulcerative colitis	7.76e-05	0.000298	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ALB—ulcerative colitis	7.66e-05	0.000294	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—ulcerative colitis	7.32e-05	0.000281	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—ulcerative colitis	6.7e-05	0.000257	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	6.69e-05	0.000257	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JAK2—ulcerative colitis	6.61e-05	0.000254	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ALB—ulcerative colitis	6.58e-05	0.000253	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RELA—ulcerative colitis	6.4e-05	0.000246	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JAK2—ulcerative colitis	6.37e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JAK2—ulcerative colitis	6.37e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RELA—ulcerative colitis	6.17e-05	0.000237	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RELA—ulcerative colitis	6.17e-05	0.000237	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—ulcerative colitis	6.04e-05	0.000232	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CHP1—ulcerative colitis	5.91e-05	0.000227	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—ulcerative colitis	5.81e-05	0.000223	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—ulcerative colitis	5.81e-05	0.000223	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JAK2—ulcerative colitis	5.78e-05	0.000222	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—ulcerative colitis	5.77e-05	0.000222	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—ulcerative colitis	5.76e-05	0.000221	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—ulcerative colitis	5.74e-05	0.00022	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RELA—ulcerative colitis	5.6e-05	0.000215	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—ulcerative colitis	5.55e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—ulcerative colitis	5.55e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—ulcerative colitis	5.52e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—ulcerative colitis	5.52e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—ulcerative colitis	5.46e-05	0.00021	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NFKB1—ulcerative colitis	5.4e-05	0.000207	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—ulcerative colitis	5.28e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—ulcerative colitis	5.26e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—ulcerative colitis	5.26e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NFKB1—ulcerative colitis	5.2e-05	0.0002	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NFKB1—ulcerative colitis	5.2e-05	0.0002	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JAK2—ulcerative colitis	5.12e-05	0.000196	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DLD—ulcerative colitis	5.1e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—ulcerative colitis	5.04e-05	0.000194	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—ulcerative colitis	5.02e-05	0.000193	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RELA—ulcerative colitis	4.95e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—ulcerative colitis	4.85e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—ulcerative colitis	4.77e-05	0.000183	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFKB1—ulcerative colitis	4.72e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—ulcerative colitis	4.67e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—ulcerative colitis	4.67e-05	0.000179	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—ulcerative colitis	4.67e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—ulcerative colitis	4.5e-05	0.000173	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—ulcerative colitis	4.46e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—ulcerative colitis	4.33e-05	0.000166	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—ulcerative colitis	4.33e-05	0.000166	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—ulcerative colitis	4.24e-05	0.000163	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—ulcerative colitis	4.22e-05	0.000162	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CHP1—ulcerative colitis	4.19e-05	0.000161	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKB1—ulcerative colitis	4.18e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—ulcerative colitis	3.93e-05	0.000151	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—ulcerative colitis	3.75e-05	0.000144	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—ulcerative colitis	3.7e-05	0.000142	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DLD—ulcerative colitis	3.62e-05	0.000139	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—ulcerative colitis	3.57e-05	0.000137	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—ulcerative colitis	3.57e-05	0.000137	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—ulcerative colitis	3.48e-05	0.000134	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—ulcerative colitis	3.39e-05	0.00013	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—ulcerative colitis	3.26e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—ulcerative colitis	3.26e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—ulcerative colitis	3.24e-05	0.000124	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—ulcerative colitis	2.96e-05	0.000114	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—ulcerative colitis	2.87e-05	0.00011	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CHP1—ulcerative colitis	2.74e-05	0.000105	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—ulcerative colitis	2.62e-05	0.000101	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS1—ulcerative colitis	2.47e-05	9.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DLD—ulcerative colitis	2.37e-05	9.09e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CALM3—ulcerative colitis	2.22e-05	8.53e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.75e-05	6.72e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—ulcerative colitis	1.73e-05	6.63e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADCY5—ulcerative colitis	1.61e-05	6.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.58e-05	6.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.23e-05	4.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—ulcerative colitis	1.2e-05	4.61e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.14e-05	4.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.14e-05	4.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—ulcerative colitis	1.08e-05	4.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.03e-05	3.96e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—ulcerative colitis	9.45e-06	3.63e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—ulcerative colitis	8.53e-06	3.27e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—ulcerative colitis	8.01e-06	3.08e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—ulcerative colitis	7.67e-06	2.94e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADCY5—ulcerative colitis	7.47e-06	2.87e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—ulcerative colitis	6.71e-06	2.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.57e-06	2.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—ulcerative colitis	5.01e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.39e-06	1.68e-05	CbGpPWpGaD
